Dr. Marco Ertreo, MD

Dr. Ertreo practices at Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York.

Dr. Ertreo's NPI, 1265827224, was assigned on April 6, 2015. Dr. Ertreo holds New York license 310483.

Dr. Ertreo's primary practice is Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD, at 1000 South Ave, Rochester, NY 14620.

Dr. Ertreo's primary practice is Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York. Dr. Ertreo is also affiliated with Highland Hospital. The medical group on file is UR Medicine Imaging Sciences (Radiology). Dmand AI also links Dr. Ertreo to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ertreo practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Ertreo's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Ertreo is licensed in New York.

CMS data shows 137 Medicare services from Dr. Ertreo across 8 procedure codes in 2024, for 168 Medicare patients. Medicare paid $6,356 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 168 Medicare patients who saw Dr. Ertreo in 2024. The largest group is under 65, with 62 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 47% are also on Medicaid. Their average risk score is 4.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ertreo's median patient age at 65, with 47% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Ertreo for performance year 2024, reported as part of a group. Dr. Ertreo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ertreo as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 19 general payments to Dr. Ertreo from 9 drug and device companies from 2020 to 2025. Consulting fees make up the largest share, 56% of the total. Carestream Health, Inc. paid the most, $3,750.